Types of genetic testing and their advantages and disadvantages
Test type . | Advantages . | Disadvantages . | Example of best use . |
---|---|---|---|
Sanger sequencing (single gene) | • Less expensive | • Only provides information on one gene | Confirmation of known variant in affected family |
• Fast turnaround | |||
Gene panel | • More in-depth coverage of genes of interest | • Does not interrogate genes outside of panel (may miss novel associations) | Clinical scenario provides suspected diagnosis for confirmation |
• Custom designed to disease of interest | • Utility depends on frequency of panel update | ||
• No secondary findings | |||
• Generally faster turnaround | |||
Whole exome | • Agnostic and comprehensive | • Insensitive to deletions/duplications, depending on technique | Novel syndrome unclear diagnosis |
• Allows identification of novel variants | • Reading depth influences ability to find variants in some genes | ||
• May be more readily available (not custom) | • Expensive | ||
Whole genome | • Allows sequencing of noncoding regions | • Expensive | Suspected genetic disease due to noncoding variant |
• Better than WES at detecting indels/duplications/inversions | • Lower read depth for some areas | ||
CGH array | • Detects large genomic changes | • Insensitive to single-nucleotide changes | Chromosomal deletions, loss |
Test type . | Advantages . | Disadvantages . | Example of best use . |
---|---|---|---|
Sanger sequencing (single gene) | • Less expensive | • Only provides information on one gene | Confirmation of known variant in affected family |
• Fast turnaround | |||
Gene panel | • More in-depth coverage of genes of interest | • Does not interrogate genes outside of panel (may miss novel associations) | Clinical scenario provides suspected diagnosis for confirmation |
• Custom designed to disease of interest | • Utility depends on frequency of panel update | ||
• No secondary findings | |||
• Generally faster turnaround | |||
Whole exome | • Agnostic and comprehensive | • Insensitive to deletions/duplications, depending on technique | Novel syndrome unclear diagnosis |
• Allows identification of novel variants | • Reading depth influences ability to find variants in some genes | ||
• May be more readily available (not custom) | • Expensive | ||
Whole genome | • Allows sequencing of noncoding regions | • Expensive | Suspected genetic disease due to noncoding variant |
• Better than WES at detecting indels/duplications/inversions | • Lower read depth for some areas | ||
CGH array | • Detects large genomic changes | • Insensitive to single-nucleotide changes | Chromosomal deletions, loss |
CGH, comparative genomic hybridization; WES, whole-exome sequencing.